Roberto Lorusso
Research Subjects
Roberto Lorusso has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Sandro Gelsomino
Cardiothoracic Department, Maastricht University Hospital, 6229 Maastricht, The Netherlands
3 shared publications - Davide Farina
Radiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Spedali Civili, Piazzale Spedali Civili 1, 25123 Brescia, Italy
2 shared publications Enrico Vizzardi
Spedali Civili Hospital
2 shared publicationsGiuseppe De Cicco
2 shared publicationsPompilio Faggiano
2 shared publicationsAttilio Renzulli
Cardiac Surgery Units, Brescia and Catanzaro
1 shared publication
Latest Publications
- 1 January 2015
- Published by Springer Nature
- p. 65-73
The Early Phase of Clinical Application: Lessons Learned
- 1 January 2015
- Published by Springer Nature
- p. 65-73
The Early Phase of Clinical Application: Lessons Learned
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (2) , e329-e330
Posterior reversible encephalopathy syndrome in a patient submitted to extracorporeal membrane oxygenation for acute fulminant myocarditis
- 1 March 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 172 (2) , e329-e330
Posterior reversible encephalopathy syndrome in a patient submitted to extracorporeal membrane oxygenation for acute fulminant myocarditis
- 1 December 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (6) , e59-e61
Pseudo-dextrocardia: An unusual case of giant biatrial enlargement
- 1 December 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (6) , e59-e61
Pseudo-dextrocardia: An unusual case of giant biatrial enlargement
- 1 March 2013
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 28 (2) , 158-163
Sutureless aortic valve replacement
Purpose of review The sutureless aortic bioprosthesis has been recently introduced in clinical practice for aortic valve replacement (SU-AVR) and appears to provide enhanced implantability and favourable haemodynamics, particularly advisable in minimally invasive surgery, in difficult anatomical situations or elderly patients. Implants of sutureless bioprosthesis are increasingly performed, and the first meaningful findings have been released and herewith analysed. Recent findings A two-centre experience in 208 patients has shown safety, ease of implantation, excellent haemodynamic performance and limited aortic cross-clamp (ACC) and cardiopulmonary (cardiopulmonary bypass, CPB) times, also in the case of associated coronary artery bypass grafting. Another multicentre experience with a third sutureless, albeit stented, valve implanted in 146 patients has been also presented with early favourable results. The sutureless aortic valve has been reported to be competitive also in relation to the transcatheter aortic valve implantation (TAVI) procedure in high-risk patients, as demonstrated by a propensity score based comparative analysis in a multicentre study, with reduced paravalvular leak rate but with increased atrial fibrillation occurrence in SU-AVR cases. Other single-centre series have been published with satisfactory results in terms of excellent haemodynamic performances or of enhanced implantability in high-risk patients or during minimally invasive procedures. Summary Sutureless aortic valve replacement has been shown to be well tolerated, to provide excellent haemodynamic performance and to be particularly suitable in minimally invasive procedures or in patients with extensive calcified aortic root or with the need of short ACC and CPB times for marked comorbidities. Further evaluations are, however, still necessary to conclusively show the actual advantages of SU-AVR, also as an alternative to TAVI procedures in operable high-risk patients.
- 1 March 2013
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 28 (2) , 158-163
Sutureless aortic valve replacement
Purpose of review The sutureless aortic bioprosthesis has been recently introduced in clinical practice for aortic valve replacement (SU-AVR) and appears to provide enhanced implantability and favourable haemodynamics, particularly advisable in minimally invasive surgery, in difficult anatomical situations or elderly patients. Implants of sutureless bioprosthesis are increasingly performed, and the first meaningful findings have been released and herewith analysed. Recent findings A two-centre experience in 208 patients has shown safety, ease of implantation, excellent haemodynamic performance and limited aortic cross-clamp (ACC) and cardiopulmonary (cardiopulmonary bypass, CPB) times, also in the case of associated coronary artery bypass grafting. Another multicentre experience with a third sutureless, albeit stented, valve implanted in 146 patients has been also presented with early favourable results. The sutureless aortic valve has been reported to be competitive also in relation to the transcatheter aortic valve implantation (TAVI) procedure in high-risk patients, as demonstrated by a propensity score based comparative analysis in a multicentre study, with reduced paravalvular leak rate but with increased atrial fibrillation occurrence in SU-AVR cases. Other single-centre series have been published with satisfactory results in terms of excellent haemodynamic performances or of enhanced implantability in high-risk patients or during minimally invasive procedures. Summary Sutureless aortic valve replacement has been shown to be well tolerated, to provide excellent haemodynamic performance and to be particularly suitable in minimally invasive procedures or in patients with extensive calcified aortic root or with the need of short ACC and CPB times for marked comorbidities. Further evaluations are, however, still necessary to conclusively show the actual advantages of SU-AVR, also as an alternative to TAVI procedures in operable high-risk patients.
- 1 August 2007
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 8 (8) , 642-644
Coronary-to-bronchial anastomosis: an unusual cause of hemoptysis
Coronary-to-bronchial anastomosis (CBA) is a rare anomaly. This vascular abnormality may be subclinical or be responsible for several pathophysiological events and symptoms involving the respiratory and/or the coronary system. We report the case of a patient with hemoptysis caused by this anomalous coronary-to-bronchial communication, who was concomitantly affected by aortic stenosis and coronary artery disease requiring surgical treatment. A coronary angiogram clearly demonstrated the abnormal vascular connection between the proximal right coronary artery and the bronchial arteries of the left inferior right lobe. The coronary branch was intra-operatively identified and ligated, in association with aortic valve replacement and coronary artery bypass, with an uneventful postoperative course and resolution of the respiratory symptoms. This case presents an unusual cause of hemoptysis due to CBA in patients with other cardiac comorbidities, which required surgical treatment, allowing direct ligation of the CBA. A review of the clinical and therapeutic characteristics of such a peculiar vascular abnormality is also provided.
- 1 August 2007
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 8 (8) , 642-644
Coronary-to-bronchial anastomosis: an unusual cause of hemoptysis
Coronary-to-bronchial anastomosis (CBA) is a rare anomaly. This vascular abnormality may be subclinical or be responsible for several pathophysiological events and symptoms involving the respiratory and/or the coronary system. We report the case of a patient with hemoptysis caused by this anomalous coronary-to-bronchial communication, who was concomitantly affected by aortic stenosis and coronary artery disease requiring surgical treatment. A coronary angiogram clearly demonstrated the abnormal vascular connection between the proximal right coronary artery and the bronchial arteries of the left inferior right lobe. The coronary branch was intra-operatively identified and ligated, in association with aortic valve replacement and coronary artery bypass, with an uneventful postoperative course and resolution of the respiratory symptoms. This case presents an unusual cause of hemoptysis due to CBA in patients with other cardiac comorbidities, which required surgical treatment, allowing direct ligation of the CBA. A review of the clinical and therapeutic characteristics of such a peculiar vascular abnormality is also provided.
- 1 September 2006
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 7 (9) , 719-720
Left cervical aortic arch
- 1 September 2006
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 7 (9) , 719-720
Left cervical aortic arch